Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fengreqing oral liquid
- Development stage
- Unknown
- Lead developer
- Handan Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Fengreqing oral liquid (FOL) is a Chinese patent drug, a traditional Chinese medicine (TCM) oral liquid, frequently used in clinical practice in China. It is primarily indicated for the treatment of inflammatory diseases of the upper respiratory tract, including colds, flu, and acute upper respiratory tract infections. The drug exhibits anti-inflammatory, anti-bacterial, and anti-viral properties. Its mechanism of action involves inhibiting the PI3K/AKT and NF-κB signaling pathways, promoting apoptosis, and reducing the production of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α.
- Brand names
- Fengreqing oral liquid
- Other names
- Xiao'er Fengreqing Oral Liquid
02
Targets
AKT (RAC-alpha serine/threonine-protein kinase)RELA (Nuclear Factor Kappa B Subunit p65)NFKBIA (NFKB inhibitor alpha)NFKB1 (NF-κB1)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)
Beyond the preview
Go deeper on Fengreqing oral liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fengreqing oral liquid.